{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Ocala",
      "address_1": "1210 SW 33rd Avenue",
      "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.",
      "address_2": "",
      "product_quantity": "1 unit",
      "code_info": "Rx #:   0400257",
      "center_classification_date": "20120810",
      "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies",
      "state": "FL",
      "product_description": "DEXAMETHASONE/BACTERIOSTATIC WATER  IONTOPHORESIS  0.5MG/5ML(0.1MG/ML) INJECTABL 30 ML (1 PRODUCT)    \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t40 ML  DEXAMETHASONE SDPF (0.1ML SYRINGE, 31G, 5/16\" ) 0.4MG/ML INJECTABLE\t0.3 ML  \t0.5 ML  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 10MG/ML (1%) INJECTABLE\t0.05 ML  \t1 ML  \t16 ML  \t  \t  \t  \t  \t2 ML  \t  \t24 ML  \t  \t  \t3 ML  \t  \t  \t32 ML  \t8 ML  \t  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 4MG/ML (0.4%) INJECTABLE\t0.4 ML  \t2 ML  \t3 ML  \t  \t5 ML  \t6 ML  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 80MG/ML (8%) INJECTABLE\t100 ML  \t40 ML  \t  \t  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 8MG/ML (800MCG/0.1ML) INJECTABLE\t0.1 ML  DEXAMETHASONE SODIUM PHOSPHATE 40MG/ML INJECTABLE\t50 ML  DEXAMETHASONE SODIUM PHOSPHATE 4MG/ML INJECTABLE\t100 ML  \t  \t  \t180 MLS  \t  \t240 MLS  \t30 ML  \t60 ML  DEXAMETHASONE SODIUM PHOSPHATE IN BSS (P.F.) 10MG/ML (1%) INJECTABLE\t1 ML  \t  \t  DEXAMETHASONE SODIUM PHOSPHATE, 30ML VIAL** 4MG/ML INJECTABLE\t30 ML  DEXAMETHASONE SOLUTION - NACL, P.F. 0.1% OPHTHALMIC\t15 ML  \t  \t  DEXAMETHASONE, SDPF - (0.07ML SYRINGE, 30G, 1/2\") 80MG/ML INJECTABLE\t0.35 ML  \t  \t0.7 ML",
      "report_date": "20120822",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab",
      "recall_number": "D-1498-2012",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "62416",
      "termination_date": "20140813",
      "more_code_info": "",
      "recall_initiation_date": "20120525",
      "postal_code": "34474-5138",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}